What we do
Orikami and Radboudumc address the need for improved tools for remote monitoring of cognitive performance19 October 2021
Highlighted by the need for new, large-scale dementia-prevention and treatment trials, clinicians and researchers urgently need improved tools for remote monitoring of cognitive performance.
New start-up Patholyt will bring AI research into pathology diagnostics21 September 2021
Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Patholyt is a spin-off from Radboudumc, a frontrunner in computational pathology research.